MALVERN, Pa. (AP) — MALVERN, Pa. (AP) — Ocugen, Inc. (OCGN) on Wednesday reported a loss of $13.9 million in its fourth quarter.
On a per-share basis, the Malvern, Pennsylvania-based company said it had a loss of 5 cents.
The biotech knee implant developer posted revenue of $764,000 in the period.
For the year, the company reported a loss of $54 million, or 20 cents per share. Revenue was reported as $4.1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCGN at https://www.zacks.com/ap/OCGN
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
